Lamisil 10 mg/g dermalno pršilo, prašek Սլովենիա - սլովեներեն - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lamisil 10 mg/g dermalno pršilo, prašek

novartis consumer health gmbh - terbinafin - dermalno pršilo, prašek - terbinafin 8,8 mg / 1 g - terbinafin

Lamisil CS 10 mg/g dermalno pršilo, raztopina Սլովենիա - սլովեներեն - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lamisil cs 10 mg/g dermalno pršilo, raztopina

novartis consumer health gmbh - terbinafin - dermalno pršilo, raztopina - terbinafin 8,8 mg / 1 g - terbinafin

Lamisil CS 10 mg/g dermalno pršilo, raztopina Սլովենիա - սլովեներեն - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lamisil cs 10 mg/g dermalno pršilo, raztopina

novartis consumer health gmbh - terbinafin - dermalno pršilo, raztopina - terbinafin 8,8 mg / 1 ml - terbinafin

Lamisil 10 mg/g dermalno pršilo, raztopina Սլովենիա - սլովեներեն - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lamisil 10 mg/g dermalno pršilo, raztopina

glaxosmithkline dungarvan ltd - terbinafin - dermalno pršilo, raztopina - terbinafin 8,8 mg / 1 g - terbinafin

Lamisil DermGel 10 mg/g gel Սլովենիա - սլովեներեն - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lamisil dermgel 10 mg/g gel

glaxosmithkline consumer healthcare (uk) trading limited - terbinafin - gel - terbinafin 10 mg / 1 g - terbinafin

Terbinafin Mylan 10 mg/g krema Սլովենիա - սլովեներեն - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

terbinafin mylan 10 mg/g krema

krema - terbinafin

Lamisil DermGel 10 mg/g gel Սլովենիա - սլովեներեն - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lamisil dermgel 10 mg/g gel

glaxosmithkline consumer healthcare (uk) trading limited - terbinafin - gel - terbinafin 10 mg / 1 g - terbinafin

CircoMax Myco Եվրոպական Միություն - սլովեներեն - EMA (European Medicines Agency)

circomax myco

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - imunologija za suidae - prašičev (za pitanje) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection.  onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.  duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.  in addition, vaccination has been shown to reduce body weight gain losses under field conditions.